Literature DB >> 29508251

Electroacupuncture Alleviates Motor Symptoms and Up-Regulates Vesicular Glutamatergic Transporter 1 Expression in the Subthalamic Nucleus in a Unilateral 6-Hydroxydopamine-Lesioned Hemi-Parkinsonian Rat Model.

Yanyan Wang1,2,3, Yong Wang4,5,6, Junhua Liu1,2,3, Xiaomin Wang7,8,9.   

Abstract

Previous studies have shown that electroacupuncture (EA) promotes recovery of motor function in Parkinson's disease (PD). However the mechanisms are not completely understood. Clinically, the subthalamic nucleus (STN) is a critical target for deep brain stimulation treatment of PD, and vesicular glutamate transporter 1 (VGluT1) plays an important role in the modulation of glutamate in the STN derived from the cortex. In this study, a 6-hydroxydopamine (6-OHDA)-lesioned rat model of PD was treated with 100 Hz EA for 4 weeks. Immunohistochemical analysis of tyrosine hydroxylase (TH) showed that EA treatment had no effect on TH expression in the ipsilateral striatum or substantia nigra pars compacta, though it alleviated several of the parkinsonian motor symptoms. Compared with the hemi-parkinsonian rats without EA treatment, the 100 Hz EA treatment significantly decreased apomorphine-induced rotation and increased the latency in the Rotarod test. Notably, the EA treatment reversed the 6-OHDA-induced down-regulation of VGluT1 in the STN. The results demonstrated that EA alleviated motor symptoms and up-regulated VGluT1 in the ipsilateral STN of hemi-parkinsonian rats, suggesting that up-regulation of VGluT1 in the STN may be related to the effects of EA on parkinsonian motor symptoms via restoration of function in the cortico-STN pathway.

Entities:  

Keywords:  Electroacupuncture; Motor behavior; Parkinson’s disease; Vesicular glutamate transporter 1

Mesh:

Substances:

Year:  2018        PMID: 29508251      PMCID: PMC5960449          DOI: 10.1007/s12264-018-0213-y

Source DB:  PubMed          Journal:  Neurosci Bull        ISSN: 1995-8218            Impact factor:   5.203


  37 in total

Review 1.  Functional significance of the cortico-subthalamo-pallidal 'hyperdirect' pathway.

Authors:  Atsushi Nambu; Hironobu Tokuno; Masahiko Takada
Journal:  Neurosci Res       Date:  2002-06       Impact factor: 3.304

2.  Electro-acupuncture stimulation acts on the basal ganglia output pathway to ameliorate motor impairment in Parkinsonian model rats.

Authors:  Jun Jia; Bo Li; Zuo-Li Sun; Fen Yu; Xuan Wang; Xiao-Min Wang
Journal:  Behav Neurosci       Date:  2010-04       Impact factor: 1.912

3.  Cortico-subthalamic inputs from the motor, limbic, and associative areas in normal and dopamine-depleted rats are not fully segregated.

Authors:  Marcus L F Janssen; Yasin Temel; Claire Delaville; Daphne G M Zwartjes; Tjitske Heida; Philippe De Deurwaerdère; Veerle Visser-Vandewalle; Abdelhamid Benazzouz
Journal:  Brain Struct Funct       Date:  2016-12-24       Impact factor: 3.270

4.  Resting state fMRI reveals increased subthalamic nucleus-motor cortex connectivity in Parkinson's disease.

Authors:  Simon Baudrexel; Torsten Witte; Carola Seifried; Frederic von Wegner; Florian Beissner; Johannes C Klein; Helmuth Steinmetz; Ralf Deichmann; Jochen Roeper; Rüdiger Hilker
Journal:  Neuroimage       Date:  2011-01-19       Impact factor: 6.556

Review 5.  The loading of neurotransmitters into synaptic vesicles.

Authors:  B Gasnier
Journal:  Biochimie       Date:  2000-04       Impact factor: 4.079

6.  Subthalamic nucleus neurons are synchronized to primary motor cortex local field potentials in Parkinson's disease.

Authors:  Shoichi A Shimamoto; Elena S Ryapolova-Webb; Jill L Ostrem; Nicholas B Galifianakis; Kai J Miller; Philip A Starr
Journal:  J Neurosci       Date:  2013-04-24       Impact factor: 6.167

7.  Therapeutic deep brain stimulation in Parkinsonian rats directly influences motor cortex.

Authors:  Qian Li; Ya Ke; Danny C W Chan; Zhong-Ming Qian; Ken K L Yung; Ho Ko; Gordon W Arbuthnott; Wing-Ho Yung
Journal:  Neuron       Date:  2012-12-06       Impact factor: 17.173

8.  Electrical stimulation of the subthalamic nucleus in advanced Parkinson's disease.

Authors:  P Limousin; P Krack; P Pollak; A Benazzouz; C Ardouin; D Hoffmann; A L Benabid
Journal:  N Engl J Med       Date:  1998-10-15       Impact factor: 91.245

9.  NMDA Receptors Containing the GluN2D Subunit Control Neuronal Function in the Subthalamic Nucleus.

Authors:  Sharon A Swanger; Katie M Vance; Jean-François Pare; Florence Sotty; Karina Fog; Yoland Smith; Stephen F Traynelis
Journal:  J Neurosci       Date:  2015-12-02       Impact factor: 6.167

10.  Electro-acupuncture improves behavior and upregulates GDNF mRNA in MFB transected rats.

Authors:  Xi-Bin Liang; Yong Luo; Xian-Yu Liu; Jun Lu; Feng-Qiao Li; Qian Wang; Xiao-Min Wang; Ji-Sheng Han
Journal:  Neuroreport       Date:  2003-06-11       Impact factor: 1.837

View more
  4 in total

1.  Internal States Influence the Representation and Modulation of Food Intake by Subthalamic Neurons.

Authors:  Haichuan Wu; Xiang Yan; Dongliang Tang; Weixin Gu; Yiwen Luan; Haijiang Cai; Chunyi Zhou; Cheng Xiao
Journal:  Neurosci Bull       Date:  2020-06-21       Impact factor: 5.203

2.  Responses of Primary Afferent Fibers to Acupuncture-Like Peripheral Stimulation at Different Frequencies: Characterization by Single-Unit Recording in Rats.

Authors:  Ran Huo; Song-Ping Han; Feng-Yu Liu; Xiao-Jing Shou; Ling-Yu Liu; Tian-Jia Song; Fu-Jun Zhai; Rong Zhang; Guo-Gang Xing; Ji-Sheng Han
Journal:  Neurosci Bull       Date:  2020-05-11       Impact factor: 5.203

Review 3.  Glutamic Acid Transporters: Targets for Neuroprotective Therapies in Parkinson's Disease.

Authors:  Xiang Li; Wenjun Wang; Jianghong Yan; Fancai Zeng
Journal:  Front Neurosci       Date:  2021-06-16       Impact factor: 4.677

Review 4.  Research progress on the role of type I vesicular glutamate transporter (VGLUT1) in nervous system diseases.

Authors:  Xianchao Du; Jiashuo Li; Minghui Li; Xinxin Yang; Zhipeng Qi; Bin Xu; Wei Liu; Zhaofa Xu; Yu Deng
Journal:  Cell Biosci       Date:  2020-03-04       Impact factor: 7.133

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.